| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/23/2001 | EP1100821A2 Anti-inflammatory compounds |
| 05/23/2001 | EP1100820A1 Pectic substance as a growth factor stabilizer |
| 05/23/2001 | EP1100819A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 05/23/2001 | EP1100818A1 Inhibitors of hiv membrane fusion |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100815A1 Protease susceptibility ii |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100811A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100810A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
| 05/23/2001 | EP1100536A2 Live attenuated salmonella vaccines to control avian pathogens |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100532A2 Methods of using lanreotide, a somatostatin analogue |
| 05/23/2001 | EP1100530A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100523A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP1100308A1 Copper transporter in ethylene signaling pathway |
| 05/23/2001 | EP1012255A4 Enhancement of growth in plants |
| 05/23/2001 | EP0986533A4 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 05/23/2001 | EP0932622A4 Vitamin d response element binding protein |
| 05/23/2001 | EP0877761B1 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof |
| 05/23/2001 | EP0789709B1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 05/23/2001 | EP0701127B1 Method of testing neurotoxicity of poliovirus vaccine |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0667900B1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/23/2001 | EP0215907B1 Parasite-derived resistance |
| 05/23/2001 | DE19955408A1 New invertebrate gamma-aminobutyric acid receptor proteins, useful in screening for potential insecticides, for plant protection or medicine, also related nucleic acid |
| 05/23/2001 | CN1296495A TPAACE06: human PTD 016 |
| 05/23/2001 | CN1296014A Novel human growth arrestin and coding sequence thereof |
| 05/23/2001 | CN1296013A Novel human membrane granulosa protein and coding sequence |
| 05/23/2001 | CN1296012A Process for preparing marine conidae analgesic polypeptide |
| 05/23/2001 | CN1066246C Axial flow valve system for linear compressor |
| 05/23/2001 | CN1066065C Interferon solution |
| 05/23/2001 | CA2290231A1 Diagnostic and therapeutic methods in autoimmune disease |
| 05/22/2001 | US6236946 Nuclear receptor ligands and ligand binding domains |
| 05/22/2001 | US6235975 Leafy cotyledon1 genes and methods of modulating embryo development in transgenic plants |
| 05/22/2001 | US6235974 Administering polypeptide |
| 05/22/2001 | US6235973 Expression of magainin and PGL classes of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 05/22/2001 | US6235972 Polynucleotide |
| 05/22/2001 | US6235968 Detecting angiogenesis |
| 05/22/2001 | US6235967 Metastasis models using green fluorescent protein as a marker |
| 05/22/2001 | US6235888 Isolated nucleic acid |
| 05/22/2001 | US6235885 Central nervous system disorders |
| 05/22/2001 | US6235882 Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina |
| 05/22/2001 | US6235881 Polypeptides encoded by novel HIV-2 proviruses |
| 05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
| 05/22/2001 | US6235879 Apoptosis modulators that interact with the Huntington's disease gene |
| 05/22/2001 | US6235878 Apoptosis induction |
| 05/22/2001 | US6235874 Production of biologically active recombinant insulin-like growth factor II polypeptides |
| 05/22/2001 | US6235873 Dimerization |
| 05/22/2001 | US6235872 Genetic engineering |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235716 Multivalent ligands which modulate angiogenesis |
| 05/22/2001 | US6235715 Human membrane recycling proteins |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235711 Cell adhesion ihibiting compounds |
| 05/22/2001 | US6235710 Spray dried erythropoietin |
| 05/22/2001 | US6235708 Testis-specific cystatin-like protein cystatin T |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235524 Compositions and methods for screening agents that inhibit MAPK mediated anti-apoptotic signals |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235518 Recombinant immunogenic actinomycetale |
| 05/22/2001 | US6235509 Process for inhibiting serine proteases using cresol or 3-hydroxypyridine and sulfonic acid derivatives or fluorophosphonates |
| 05/22/2001 | US6235500 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 05/22/2001 | US6235498 Propagating mammalian aggregations; transform aggregates with nucleotide sequences which express insulin and heterologous polypeptide, propagate aggregates |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235496 Nucleic acid encoding mammalian mu opioid receptor |
| 05/22/2001 | US6235482 Strawberry promoters and genes |
| 05/22/2001 | US6235477 Purified polypeptide |
| 05/22/2001 | US6235470 Detection of neoplasia by analysis of saliva |
| 05/22/2001 | US6235469 Generation of transcriptional sequences associated with phage envelope protein; incubate and insert nucleotide sequences into expression vector, express gene coded in vector and recover polypeptides |
| 05/22/2001 | US6235467 Methods for identifying cell cycle regulators |
| 05/22/2001 | US6235290 DNA immunization against chlaymdia infection |
| 05/22/2001 | US6235288 An hepatitis b virus immunogenic peptide comprising a peptide of 50 amino acids or less in length comprises at least seven contiguous amino acids of specific amino acid sequences, binds to an hla molecule to form a complex |
| 05/22/2001 | US6235284 Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
| 05/22/2001 | US6235283 An isolated polypeptide encoded by a polynucleotide sequence that hybridizes to the complementary strand of an isolated polynucleotide sequence encoding specific amino acid sequence; produces immune response against tick infestationinfestation |
| 05/22/2001 | US6235278 Biological insect control agents expressing insect-specific toxin genes, methods and compositions |
| 05/22/2001 | US6235263 Carboxy-terminal BRCA1 interacting protein |
| 05/22/2001 | CA2078572C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 05/22/2001 | CA1341236C Process for producing recombinant human factor viii: c and transformant to be used therefor |
| 05/22/2001 | CA1341235C Modular assembly of antibody genes, antibodies prepared thereby and use |
| 05/21/2001 | WO2001036465A2 Human zven proteins |
| 05/21/2001 | CA2392128A1 Human zven proteins |
| 05/17/2001 | WO2001035255A2 Large scale comparative protein structure modeling |
| 05/17/2001 | WO2001035102A2 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | WO2001035096A2 Diseases associated with altered mitochondrial function |
| 05/17/2001 | WO2001034841A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034829A2 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 05/17/2001 | WO2001034824A2 Methods and compositions comprising renilla gfp |
| 05/17/2001 | WO2001034823A2 Method for enhancing resistance in plants |
| 05/17/2001 | WO2001034822A2 Control of post-transcriptional gene silencing in plants |